documents: FDA-2017-D-3101-0017
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-D-3101-0017 | FDA | FDA-2017-D-3101 | Abbreviated New Drug Applications: Pre-Submission Facility Correspondence Related to Prioritized Generic Drug Submissions; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2022-12-05T05:00:00Z | 2022 | 12 | 2022-12-05T05:00:00Z | 2022-12-05T13:29:25Z | 2022-26412 | 0 | 0 | 09000064855196fa |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref